Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma

Background: Hepatocellular carcinoma represents the most common primary malignancy of all liver cancer types and its prognosis is usually unsatisfactory. TSEN54 encodes a protein constituting a subunit of the tRNA splicing endonuclease heterotetramer. Previous researches concentrated on the contribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Bidong, Zhou, Minqin, Song, Gelin, Zeng, Hong, Gong, Yiyang, Jiang, Yike, Ke, Yun, Huang, Da, Peng, Hong, Li, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120902/
https://www.ncbi.nlm.nih.gov/pubmed/37059591
http://dx.doi.org/10.18632/aging.204645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120902/
https://www.ncbi.nlm.nih.gov/pubmed/37059591
http://dx.doi.org/10.18632/aging.204645

Ejemplares similares